UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Radiation oncology (London, England), 2021-09, Vol.16 (1), p.1-176, Article 176

2021

Volltextzugriff (PDF)

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4007-4014

2015

Volltextzugriff (PDF)

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.492-499

2012

Volltextzugriff (PDF)

Too Good to be True?

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.507-508

2021

Volltextzugriff (PDF)

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Lung cancer (Amsterdam, Netherlands), 2021-04, Vol.154, p.51-61

2021

Volltextzugriff (PDF)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

EJNMMI research, 2021-07, Vol.11 (1), p.68-68, Article 68

2021

Volltextzugriff (PDF)

Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non–small cell lung cancer

Investigational new drugs, 2014-02, Vol.32 (1), p.123-134

2014

Volltextzugriff (PDF)

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

Frontiers in immunology, 2013-01, Vol.4, p.33-33

2013

Volltextzugriff (PDF)

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

Journal of thoracic oncology, 2024-05, Vol.19 (5), p.786-802

2024

Volltextzugriff (PDF)

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.54-64

2017

Volltextzugriff (PDF)

Multimodal treatment of non-small-cell lung cancer

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1018-1020

2015

Volltextzugriff (PDF)

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition

Cancer management and research, 2020-01, Vol.12, p.7881-7890

2020

Volltextzugriff (PDF)

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Der Onkologe, 2018-12, Vol.24 (12), p.974-982

2018

Volltextzugriff (PDF)

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)

International journal of cancer, 2024-06, Vol.154 (11), p.1967-1978

2024

Volltextzugriff (PDF)

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

The Journal of thoracic and cardiovascular surgery, 2010-06, Vol.139 (6), p.1424-1430

2010

Volltextzugriff (PDF)

HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model

Lung cancer (Amsterdam, Netherlands), 2020-06, Vol.144, p.20-29

2020

Volltextzugriff (PDF)

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

Journal of Nuclear Medicine, 2021-12, Vol.62 (12), p.1684-1691

2021

Volltextzugriff (PDF)

The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)

Lung cancer (Amsterdam, Netherlands), 2012-07, Vol.77 (1), p.183-191

2012

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2667-2674

2011

Volltextzugriff (PDF)

Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements

Current opinion in oncology, 2014-03, Vol.26 (2), p.171-181

2014

Volltextzugriff (PDF)

ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-11, Vol.149, p.10-16

2020

Volltextzugriff (PDF)

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Biochemical and biophysical research communications, 2018-06, Vol.500 (3), p.621-625

2018

Volltextzugriff (PDF)

Intensified High-Dose Chemoradiotherapy With Induction Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer—Safety and Toxicity Results Within a Prospective Trial

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.809-815

2010

Volltextzugriff (PDF)

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Theranostics, 2024-08, Vol.14 (14), p.5400-5412

2024

Volltextzugriff (PDF)

Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer

Journal of thoracic disease, 2018-08, Vol.10 (S22), p.S2682-S2685

2018

Volltextzugriff (PDF)

26 – 50 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(131)
Tagungsberichte
(1)

Sprache

Englisch
(127)
Deutsch
(4)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(98)
Oncology
(87)
Humans
(85)
Lung Neoplasms - Pathology
(50)
Male
(49)
Female
(48)
Middle Aged
(43)
Aged
(40)
Respiratory System
(40)
Lung Cancer
(37)
Adult
(34)
Lung Neoplasms - Drug Therapy
(34)
Neoplasm Staging
(34)
Carcinoma, Non-Small-Cell Lung - Pathology
(31)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(28)
Tumors
(26)
Prognosis
(25)
Aged, 80 And Over
(23)
Biological And Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines

Too Good to be True?

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard

Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non–small cell lung cancer

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Multimodal treatment of non-small-cell lung cancer

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements

ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

Intensified High-Dose Chemoradiotherapy With Induction Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer—Safety and Toxicity Results Within a Prospective Trial

Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival

Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer

Suchergebnisse filtern